These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18360568)

  • 1. Duloxetine in the treatment of stress urinary incontinence.
    Jost WH; Marsalek P
    Ther Clin Risk Manag; 2005 Dec; 1(4):259-64. PubMed ID: 18360568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.
    Jost W; Marsalek P
    Clin Auton Res; 2004 Aug; 14(4):220-7. PubMed ID: 15316838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin and norepinephrine involvement in efferent pathways to the urethral rhabdosphincter: implications for treating stress urinary incontinence.
    Thor KB
    Urology; 2003 Oct; 62(4 Suppl 1):3-9. PubMed ID: 14550831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat.
    Thor KB; Katofiasc MA
    J Pharmacol Exp Ther; 1995 Aug; 274(2):1014-24. PubMed ID: 7636716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine: a new approach for treating stress urinary incontinence.
    Moore K
    Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S53-62. PubMed ID: 15302567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duloxetine: a new pharmacologic therapy for stress urinary incontinence.
    Nitti VW
    Rev Urol; 2004; 6 Suppl 3(Suppl 3):S48-55. PubMed ID: 16985864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats.
    Katofiasc MA; Nissen J; Audia JE; Thor KB
    Life Sci; 2002 Aug; 71(11):1227-36. PubMed ID: 12106588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of stress urinary incontinence with duloxetine hydrochloride.
    Sweeney DD; Chancellor MB
    Rev Urol; 2005; 7(2):81-6. PubMed ID: 16985814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coadministration of low-dose serotonin/noradrenaline reuptake inhibitor (SNRI) duloxetine with α 2-adrenoceptor blockers to treat both female and male mild-to-moderate stress urinary incontinence (SUI).
    Alberti C
    G Chir; 2013; 34(7-8):189-94. PubMed ID: 24091172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What do we know about duloxetine's mode of action? Evidence from animals to humans.
    Schuessler B
    BJOG; 2006 May; 113 Suppl 1():5-9. PubMed ID: 16529563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence.
    Zinner NR
    Expert Opin Investig Drugs; 2003 Sep; 12(9):1559-66. PubMed ID: 12943499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for stress urinary incontinence : present and future options.
    Zinner NR; Koke SC; Viktrup L
    Drugs; 2004; 64(14):1503-16. PubMed ID: 15233589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacotherapy of stress incontinence].
    Jost WH; Marsalek P; Michel MC
    Dtsch Med Wochenschr; 2005 Oct; 130(41):2337-42. PubMed ID: 16231235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmaceutical treatment of stress incontinence. New approaches via a direct effect of duloxetine on Onuf's nucleus].
    Jost WH; Marsalek P; Manning M; Jünemann KP
    Urologe A; 2004 Oct; 43(10):1249-53. PubMed ID: 15322758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine for the treatment of post-prostatectomy stress urinary incontinence.
    Neff D; Guise A; Guralnick ML; Langenstroer P; See WA; Jacobsohn KM; O'Connor RC
    Can Urol Assoc J; 2013; 7(5-6):E260-2. PubMed ID: 23766826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Side Effects of Duloxetine in the Treatment of Depression and Stress Urinary Incontinence.
    Viktrup L; Pangallo BA; Detke MJ; Zinner NR
    Prim Care Companion J Clin Psychiatry; 2004; 6(2):65-73. PubMed ID: 15254599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting serotonin and norepinephrine receptors in stress urinary incontinence.
    Thor KB
    Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S38-52. PubMed ID: 15302566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine for management of stress urinary incontinence.
    Guay DR
    Am J Geriatr Pharmacother; 2005 Mar; 3(1):25-38. PubMed ID: 16089245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine compared with placebo for treating women with symptoms of overactive bladder.
    Steers WD; Herschorn S; Kreder KJ; Moore K; Strohbehn K; Yalcin I; Bump RC;
    BJU Int; 2007 Aug; 100(2):337-45. PubMed ID: 17511767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of efficacy of duloxetine in stress urinary incontinence in women.
    Deepak P; Kumar TN; Sen TK
    Indian J Pharmacol; 2011 Apr; 43(2):176-9. PubMed ID: 21572653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.